When the Covid-19 positive cases are increasing very fast in India, a ray of hope for vaccine is risen because our country is ready for first human clinical trials of Covid-19 vaccine named COVAXIN.
The indigenousm vaccine has been developed and manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
The Drug Controller General of India , CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the Bharat Biotech results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020 and likely to launch on August 15th if everything goes fine ,said ICMR.
We hope for the best this time that it will be successful because the graph of Covid-19 is growing faster in India. We are on the third rank of highest no of cases of Covid-19 after America and Brazil. India will very soon touch the no of 10 Lac because everyday around 20K new Covid-19 cases are coming and around 500 people are dying due to Covid-19. This is the average ratio. However, the recovery rate is very good in India it’s around 60% . But the impacts of Covid-19 on normalcy is still severe.
There are other companies too which are working on war footing and doing research on vaccine. Zydus Cadila’s DNA plasmid and measles vector vaccines as well as Serum’s codon deoptimised live attenuated vaccine, which it is developing with Codagenix, are still in the pre clinical stage, according to WHO. We thank these companies who are working to save human beings. Praying for the success of all the trials of the vaccines against Covid-19.